ACBM — Acro Biomedical Co Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Acro Biomedical Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.7 | -15.9 | -8.81 | -0.042 | -0.101 |
| Non-Cash Items | 7.66 | 15.7 | 8.56 | 0.004 | -0.053 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.341 | 0.01 | 0.236 | 0.001 | -0.042 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.299 | -0.147 | -0.015 | -0.037 | -0.196 |
| Financing Cash Flow Items | -0.242 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.222 | 0.058 | 0.01 | 0.037 | 0.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.077 | -0.089 | -0.005 | 0 | 0.004 |